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ABSTRACT
Objectives: To determine the risk of orthostatic hypotension (OH) due to antihypertensive therapy in a
geriatric inpatient population.
Subjects and methods: This observational cohort study included 388 patients (mean age 80.7, 68.5%
female) hospitalized in a geriatric clinic. OH risk was evaluated by orthostatic testing (OT), with manual
measurement of blood pressure after 30 minutes supine (T0), and after 1 (T1), 3 (T3), and 5 (T5) minutes
after rising in a vertical position. OH was deﬁned by a  20 mmHg decrease in systolic blood pressure
and/or a  10 mmHg decrease in diastolic blood pressure.
Results: Age  80 years, history of falls and prescribed medication (antihypertensive, hypotensive, or
both), were not signiﬁcantly associated with OH or with OT positivity at any time point. The multivariate
analysis showed that OH risk in T1 was 2.34 times higher than in T3 and T5 (conﬁdence interval [1.49–
3.68], P < 0.001). Presenting symptoms during OT increased the risk of obtaining a positive result by
3.67 times (conﬁdence interval [1.52–8.87], P = 0.004). With each increase in one mini-mental state
examination (MMS) point, a 9.9% decrease of OT positivity was observed (odds ratio = 0.907, conﬁdence
interval [0,84–0,98], P = 0.016).
Conclusion: The prescription of antihypertensive drugs was not signiﬁcantly associated with the risk of
OH in this geriatric inpatient population. OH screening in patients with cognitive impairment is critical,
as with each decrease in one MMS point, OH risk increased by almost 10%.
which should be used for any reference to this work1. Introduction
Although the prevalence of hypertension, particularly systolic,
has been long known to increase with age, the beneﬁts of treating
hypertension in older patients have remained controversial for a
very long time. The publication of the Hypertension in the Very
Elderly Trial (HYVET) study, in 2008, demonstrated the cardiovas-
cular beneﬁts of such treatment in patients over age 80 [1].
OH and an increased risk of falls are often perceived as a risk of
anti-hypertensive therapy. The prevalence of OH in the HYVET
study was the same in treated and control patients. However, the
population studied included patients who were relatively healthy
for their age, presented with few comorbidities and very few
medications. The risk of OH associated with treatment may be
much more important in a population of geriatric patients, due to
the impact of comorbidities and/or other drug prescriptions. The
objective of our study was to assess the risk of OH and falls§ Martial Coutaz, Katia Iglesias and Je´roˆme Morisod contributed to the concept
and design of the study, interpretation of the results, drafting of the manuscript and
ﬁnal approval of the version to be published.
* Corresponding author. Tel.: +0041 24 486 26 62; fax: +0041 24 486 26 00. 
E-mail address: martial.coutaz@hopitalvs.ch (M. Coutaz).associated with antihypertensive therapy in a hospitalized, and
thus more vulnerable, older population [2].
2. Methods
2.1. Population
We prospectively included 388 patients hospitalized in the
geriatrics department of Valais Hospital. The inclusion of patients
started in June 2009 and lasted over 11 months. Patients with
delirium, with an orthopedic or traumatologic disorder impeding
rising to a standing position, admitted for palliative care, or with an
unreliable past personal medical history for the previous 6 months
were excluded. Orthostatic testing could not be performed in
48 patients due to their inability to maintain a prolonged standing
position, although they were initially included in the study. The
time of orthostatic testing was variable during the day, and the
schedule of drug and meal administration was not known.
Drug prescriptions were classiﬁed as follows: antihypertensive
drugs (A drugs: diuretics, angiotensin-converting enzyme inhibi-
tors [ACEIs], angiotensin II antagonists [A2As], renin inhibitors,
calcium channel blockers, beta-blockers, centrally acting antihy-
pertensive drugs) and drugs with potential hypotensive (H) effects,
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2or enhancing the risk of fall via other mechanisms (H drugs:
neuroleptics, nitrate derivatives, benzodiazepines, antidepres-
sants, antiparkinsonians, opioids). The history of falls during the
previous 6 months was recorded in the observation protocol (one,
two, more than two episodes, or hospitalization due to a fall).
Cognitive function was assessed by the Mini-Mental-State [3]
(MMS), and functional abilities assessed by the Barthel Index [4],
between day 1 and day 3 after geriatric hospitalization. All patients
with delirium were excluded. Admission albumin and plasma
creatinine levels were transcribed from the medical chart,
glomerular ﬁltration rate was estimated using the Modiﬁcation
Diet in Renal Disease (MDRD) equation [5].
2.2. Measures
In the ﬁrst 24 hours, orthostatic testing (Schellong’s test) (OT)
was performed on 340 patients. Manual measurements of blood
pressure using mercury sphygmomanometers were performed
after 30 minutes in the supine position (T0), and 1 (T1), 3 (T3) and 5
(T5) minutes after rising to a vertical position. OH was deﬁned as a
decrease  20 mmHg in systolic blood pressure and/or a decrease
 10 mmHg in diastolic blood pressure. The occurrence of OH
symptoms such as vertigo, dizziness, visual disturbances, fatigue,
general weakness, headaches, slurred speech, was recorded [6,7].
2.3. Statistical analyses
To analyze OT results, which are categorical variables (positive
vs negative) measured thrice for each patient (T1, T3, and T5), a
generalized mixed effects model was used [8]. Gender, age, marital
status, Barthel Index and MMS scores, albumin and creatinine
levels, number of medications per day, hospitalization due to falls,
number of falls in the previous 6 months, type of medication taken
(A drugs or H drugs) and patients’ provenance (home, surgical
department, medical department) were included in the analyses.
All analyses were performed with the Stata software [9].
We also analyzed having at least one positive ST result during
the ﬁrst 5 minutes (T1, T3, and T5 combined) vs having only
negative ST. In order to test whether there was a differenceTable 1
Clinical characteristics of patients and Schellong’s test.
Characteristics All patients
n = 340
Age 80.7  8.2 
Age  80 years (%) 204 (60)
Female gender (%) 233 (68.5)
Living alone (%) 182 (53.5)
Provenance: home (%) 90 (26.5)
Barthel Index 70.9  19.0 
MMS 25.0  5.0 
Albumin level (g/l) 37.4  4.4 
Creatinine clearance (ml/min) 69.8  32.6 
Drugs prescribed (number/day) 7.4  3.3 
A drugs (%) 231 (67.9)
H drugs (%) 234 (68.8)
A+H drugs (%) 158 (46.5)
Fall within the previous six months (%) 146 (42.9)
Continuous variables are shown as mean  SD, and categorical variables as n (%). P-valu
parametric test depending on the distribution for continuous variables.between ST patterns and information related to patients, we used 
x2-test to analyze categorical variables and a t-test to analyz
continuous variables. When variables weren’t normally distribut
ed, Mann-Whitney non-parametric tests were performed.
3. Results
3.1. Patients
Two hundred and thirty-three women and 107 men wer
included in the study (Table 1). Their mean age was 80  8.2 year
(mean + SD). The mean MMS score was 25  5.0 points, and th
Barthel Index was 70  19.0 points. Exactly 53.5% of patients live
alone and 26.5% of patients were admitted directly from their home
In the 6 months before the study, 42.9% of patients (146/340) suffere
at least one fall. Among these patients, 57.5% (84/146) fell once, 15.7
fell twice, and 26.7% fell more than twice. Falls were the main reaso
for admission in 59.5% (87/146) patients.
3.2. Medication
The mean number of prescribed drugs was 7.4  3.2 per patien
Exactly 90.3% of the patients were taking either A or H drugs, wherea
33 patients (9.7%) did not take either medication. The prevalence o
A drug therapy was 67.9% in the whole study population, and 74.0% i
patients  80 years old. It should be noted that 234 patients (68.8%
were receiving an active substance with a potential H effect in the
daily medication ration. Taking A drug therapy didn’t promote th
occurrence of falls (44.6% in fallers versus 55.4% in non fallers), wit
the same observation for patients  80 years old (49.7% in faller
versus 50.3% in non fallers). Exactly 30.3% of the patients were takin
only one class of A drug therapy, 27.3 two, 8.8% three and 1.5% fou
classes of A drugs).
3.3. Orthostatic testing
Overall 144 patients (42.3%) had OH, deﬁned as a drop in SBP o
DBP at any of the three time points (T1, T3, T5). Forty patient
fulﬁlled OH criteria at all three time points, whereas 10 patientOH
n = 144
(42.4%)
No OH
n = 196
(57.7%)
P-value
81.3  7.7 80.3  8.59 0.303
90 (62.5) 114 (58.2) 0.420
92 (63.9) 141 (71.9) 0.114
70 (48.6) 112 (57.1) 0.119
44 (30.6) 46 (23.5) 0.143
69.3  20.0 72.1  18.3 0.303
24.0  5.5 25.6  4.4 0.018
37.0  5.0 37.6  4.0 0.506
66.8  28.8 72  35.1 0.291
7.4  3.4 7.4  3.2 0.992
99 (68.8) 132 (67.4) 0.784
98 (68.1) 136 (69.4) 0.793
66 (45.8) 92 (46.9) 0.840
67 (46.5) 79 (40.3) 0.225
es were calculated using x2-test for categorical variables and t-test or Mann-Whitney non-
Fig. 1. Positive Schellong according to age.
3had a positive ST only at T5 (T1 and T3 negative). By categorizing
STs according to measurement time, there were more positive OTs
at T1 (31.4%) than T3 (24%) or T5 (23.7%).
Patients’ characteristics according to OH status are shown in
Table 1. We observed no differences in age and in the rate of A, H or
A + H drug prescriptions in patients with or without OH. Further,
there was no signiﬁcant difference between the number of positive
OTs and the prescription of A, H or A + H drugs. The small sample
sizes may explain the latter ﬁnding (only 33 patients received
neither H nor A drugs).
The association of several A drugs didn’t increase the risk of
presenting OH. With one class of A drug, the prevalence of OH is
45.6% (versus 54.4%, P = NS), with two 36.7% (versus 63.4%, P = NS),
with three 46.7% (versus 53.3%, P = NS). Among the ﬁve patients
with four classes A drugs, four had OH but the sample is too small
and the difference not signiﬁcant.
The prevalence of OH at admission was similar in patients with
or without a history of falls (32.2% versus 30.9% in T1, 27.6% versus
21.3% in T3, P = NS). The prevalence of OH in T1 was 30.9% (22.2% in
T2) in patients < 80 and 31.9% (25.2% in T3) in patients  80
(differences not signiﬁcant). Further, there was no signiﬁcant
interaction between results at the different time points and age,
even if it seemed that the difference between age groups was more
pronounced at the latest time point (Fig. 1). In the multivariate
statistical analysis (Table 2), the MMS was inversely associated
with the prevalence of OH (odds ratio = 0.907, P = 0.016).
Moreover, presenting symptoms during the OT increased the risk
of obtaining a positive result by 3.67 times (odds ratio = 3.674,
P = 0.004). It is important to understand that symptoms associated
with performing the test are not a necessary condition for test
interpretation, ﬁrst because 12.2% of patients with negative OT
presented symptoms, and second because 85% of patients with a
positive OT in T1, 81% in T3, and 79% in T5 presented a positive OT
without associated symptoms. The risk of having a positive ST in T1
compared to T3 and T5 was 2.34 times higher (odds ratio = 2.338,
P < 0.001).
4. Discussion
OH affects 6% of elderly individuals living at home, and 50 to
68% of patients living in an institution, mainly because of theTable 2
Results of the positive Schellong test multivariate analysis.
Odds ratio Conﬁdence interval P-value
After 1 minute 2.34 [1.49–3.68] < 0.001
Symptoms 3.67 [1.52–8.87] 0.004
MMS 0.91 [0.84–0.98] 0.016simultaneous presence of several comorbidities, and the medica-
tion with several antihypertensive drugs [2,10].
In our group of 340 individuals, taking into account all blood
pressure measurements performed for each patient, 42.4%
presented a positive OT result (T1 and/or T3 and/or T5), a ﬁgure
that increased to 44.1% in patients over age 80. Even if the
population considered was hospitalized, OH prevalence seemed
relatively high, considering that these patients were living at home
and more than half of them were living alone.
None of the variables deﬁned in the clinical characteristics of
our patients was a statistically signiﬁcant factor associated with
OH, except for a decrease in the MMS score, related to the risk of
presenting a positive OT result (Tables 1 and 2). Our results showed
that each one point of increase in the MMS was associated with a
9.9% decrease in OH risk (odds ratio = 0.907, P < 0.016). Thus, we
suggest to check blood pressure with OT in demented patients,
even if the test could be more difﬁcult because of the lack of
compliance (behavioural symptoms, movements, agitation. . .).
Although theoretically, using antihypertensive drugs could
worsen OH, most published observational studies and clinical
trials have failed to consistently demonstrate this association
[11]. Our results concur with these ﬁndings, indicating that
taking an antihypertensive drug, an hypotensive drug, or a
combination of both, didn’t increase the risk of OH in our overall
sample or in patients over 80 years old. We don’t ﬁnd, as
Kamaruzzaman et al. [12], a statically signiﬁcant relation
between OH and the use of three or more antihypertensives.
Our population examined is probably too robust (Barthel Index:
70.9  19.0) because of our exclusion’s criteria, and we don’t know
the coexisting illnesses of patients (such as diabetes, cardiovascu-
lar disease, frailty, or neurological conditions) that might affect the
responses to the OT.
However, with increasing age, taking antihypertensive drugs
could promote the occurrence of OH. Poon and Braun [13], in a
retrospective study including 342 patients (96% men), with a mean
age of 82, showed that there was a statically signiﬁcant association
between OH prevalence and the number of antihypertensive or
hypotensive drugs, although we didn’t conﬁrm these results in our
study.
Additionally, Hiitola et al. [14] showed a positive correlation
between OH prevalence and the number of drugs prescribed in the
follow-up of a cohort of 653 patients aged 75 or older, living at
home, and presenting a prevalence of OH of 34%. Since
polymedication affected both the patients of this Finnish study
and the patients of our study, it is difﬁcult to pinpoint which single
drug could be responsible for an eventual OH, because of the
synergetic effects of the different drugs and their respective
interactions. In subjects consuming several drugs, it becomes
difﬁcult to estimate if OH is due to medication or to the numerous
comorbidities, or even to their association. It should also be noted
that there are very few studies on the incidence of OH with
different kinds of antihypertensive drugs [14,15].
Fall history within the previous 6 months was not a statistically
signiﬁcant prognostic factor for a positive OT in our subjects,
considering all ages. However, among the 146 patients with fall
history, 69.2% are age over 80 years old and the 3/4 were under
antihypertensive therapy. According to the recent analysis by
Tinetti [16] and the latest guidelines from the American and British
Geriatrics Societies [17], OH is one of the main factors that
predispose to falls in the elderly, and should result in a reduction or
discontinuation of certain responsible medications. According to
Woolcott [18], the classes of drugs involved are principally
antihypertensive, neuroleptics, antidepressants, and benzodiaze-
pines. These different medication classes, often prescribed in the
elderly, do not show signiﬁcant differences in OT positivity in our
study. Finally, in our study, the falls history, the prescription of
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4H drugs or for one or more classes of A drugs, don’t increase the risk
of OH, contrary to the studies cited above [12–18].
The results of our study seem to be in concordance with those of
Gangavati et al. [19], showing that antihypertensive therapy in the
elderly does not increase the risk of falls, even in the presence of
OH. The risk of a fall at 1 year, according to this study, is increased
(by 2.5) only in patients with non-controlled hypertension
(deﬁned by blood pressure equal to or greater than 140/90), and
with a positive OT after 1 minute. Moreover, in the HYVET study,
treatment for hypertension based on the prescription of a diuretic
and an angiotensin-converting enzyme inhibitor was not associ-
ated with an increase, but rather a decrease (31%) in the number of
fractures in medicated individuals [20].
According to our results, an OH in T1 is 2.34 times more likely to
occur than in T3 and T5. Measurements at 3 and 5 minutes are
nevertheless advisable, because 10 patients in our study presented
a positive OT only in T3, and 10 other patients only in T5.
OT positivity is not constantly subjected to a concomitant
occurrence of symptoms. However, their occurrence increased the
risk by 3.67 of presenting a positive OT in our study. This is
interesting because it should comfort our nurse teams to listen
attentively to the complaints of the elderly in their daily living
activities. Indeed, the complaints suggestive of OH symptoms
(vertigo, fatigue, weakness, etc.) should systematically lead to
performing an OT in order to diagnose an eventual OH.
The results of our study comprise a number of limitations.
Inclusion criteria related to performing the OT probably favored
the selection of a group of patients who were more robust,
excluding those who were weaker and admitted for palliative care,
after orthopaedic surgery, with walking or balance difﬁculties, or
with cognitive impairment, thus preventing a reliable history
check. Moreover, the analysis of the medication type didn’t take
into account the duration of antihypertensive treatment, nor if
some classes were prescribed for other conditions than hyperten-
sion (such as heart failure). In addition, the time of the test was
variable during the day, and the schedule of drug and meal
administration was not known (role in postprandial hypoten-
sion?). Finally, given the ﬂuctuations of OH during the day, the
realization of only one test per individual during the overall stay
might not allow for the detection of a portion of patients suffering
from OH.
5. Conclusions
OH prevalence concerns 44% of our hospitalized subjects over
age 80. OT is more frequently positive at one minute compared to 3
and 5 minutes. In the presence of orthostatic symptoms, OT is also
more frequently positive. Identifying patients suffering from
cognitive impairment is critical, because with each one point of
decrease in the MMS, OH risk increases by almost 10%.Although
the prescription of an antihypertensive drug did not signiﬁcantly
increase OH risk in our study, we recommend a systematic OH
screening at each visit before initiating antihypertensive therapy
or after modifying the dosage, because of the increased risk in
cardiovascular diseases (coronary heart disease, stroke, syncope),
in falls and in overall OH-associated mortality in the elderly
[2,11,14,21–23].Sponsor’s role
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